Delisting risk
Genprex (GNPX)
Develops REQORSA for lung cancer and GPX-002 for diabetes.
$3.49
Pre-market−0.01 (−0.29%)
At close$3.50(−1.41%)
Something off on this page? Send us feedback.
Next report
Dec 2, 2026
estimated · in 90 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Aug '25Aug '25Nov '25Mar '26Mar '26May '26Aug '26Dec '26
Reported−$8.50−$8.50−$5.00−$1.15−$1.15−$14.07−$9.40Pending
Estimate−$15.62−$21.00−$12.50−$286.00−$13.00———
Surprise+45.6%+59.5%+60.0%+99.6%+91.2%———
RevenueReportedEstimate
Aug '25Aug '25Nov '25Mar '26Mar '26May '26Aug '26Dec '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | — | — | — |
| Aug 2026 | — | −$9.40 | — |
| May 2026 | — | −$14.07 | — |
| Mar 2026 | −$13.00 | −$1.15 | +91.2% |
| Mar 2026 | −$286.00 | −$1.15 | +99.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Jun 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2, 2026 | — | — | — | — | — | — | — |
| Aug 14, 2026 | — | −$9.40 | — | — | — | — | −11.3% |
| May 13, 2026 | — | −$14.07 | — | — | — | — | +1.2% |
| Mar 30, 2026 | −$13.00 | −$1.15 | +91.2% | — | — | — | +2.3% |
| Mar 27, 2026 | −$286.00 | −$1.15 | +99.6% | — | — | — | −2.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 14, 2025 | |||||||
| Aug 8, 2025 | |||||||
| May 21, 2025 | |||||||
| May 12, 2025 | |||||||
| Apr 7, 2025 | |||||||
| Apr 1, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 19, 2024 | |||||||
| Aug 9, 2024 | |||||||
| May 27, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 25, 2023 | |||||||
| Aug 21, 2023 | |||||||
| May 22, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 30, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 13, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 26, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 13, 2019 | |||||||
| May 15, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Nov 27, 2017 | |||||||
| Jun 30, 2017 | |||||||